Skip to content
StockMarketAgent
Sector pending / Pharmaceutical PreparationsUpdated 2026-05-10 22:07 UTC

FRA/HPX stock hub

FRA/HPX has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

FRA/HPXis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
2.3B
Frankfurt Stock Exchange
Market data

Live price

Current market quote for this ticker.

Current price
FRA/HPX
In the news

Latest news · FRA/HPX

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 n/aP50 n/aP75 n/a
Trailing P/E22.2
P25 n/aP50 n/aP75 n/a
ROE6.8
P25 n/aP50 n/aP75 n/a
ROIC8.7
P25 n/aP50 n/aP75 n/a
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All FRA/HPX market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
222
Groups with data
11
Currency
JPY
Showing 222 of 222 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

18
MetricValue
Country
Japan
Country code
DE
Employees
2,799
Employees Change
40%
Employees Change Percent
1.45
Enterprise value
EUR 1.7B
Exchange
Frankfurt Stock Exchange
Financial currency
JPY
First seen
2026-05-10
Industry
Pharmaceutical Preparations
Last refreshed
2026-05-10
Market cap
EUR 2.3B
Price
EUR 31.8
Price currency
EUR
Rev Per Employee
315,840.27x
Sic
2834
Symbol
fra/HPX
Website
https://www.global.hisamitsu

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

13
MetricValue
Earnings Yield
4.5%
EV Earnings
16.28x
EV/EBIT
16.72x
EV/EBITDA
12.14x
EV/FCF
32.9x
EV/Sales
1.91x
FCF yield
2.23%
P/B ratio
1.44x
P/E ratio
22.2x
P/S ratio
2.61x
PE Ratio10 Y
26.77x
PE Ratio3 Y
19.54x
PE Ratio5 Y
23.98x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

24
MetricValue
EBIT Margin
10.99%
EBITDA Margin
15.32%
FCF margin
5.82%
Gross margin
58.96%
Gross Profit
EUR 521.2M
Gross Profit Growth
5.4%
Gross Profit Growth Q
8.38%
Gross Profit Growth3 Y
9.76%
Gross Profit Growth5 Y
6.8%
Net Income
EUR 103.9M
Net Income Growth
-11.94%
Net Income Growth Q
-10.23%
Net Income Growth3 Y
17.73%
Net Income Growth5 Y
15.68%
Pretax Margin
14.51%
Profit Margin
11.75%
Profit Per Employee
EUR 37,120
ROA
3.15
Roa5y
2.7
ROCE
5.66
ROE
6.81
Roe5y
5.81
ROIC
8.67
Roic5y
7.91

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

24
MetricValue
Cagr10y
-0.67%
Cagr15y
2.37%
Cagr1y
20.38%
Cagr20y
3.17%
Cagr3y
10.69%
Cagr5y
-6.09%
Div CAGR10
0.45%
Div CAGR3
0.26%
Div CAGR5
-1.23%
EPS Growth
-9.12
EPS Growth Q
-6.69
EPS Growth3 Y
21.95
EPS Growth5 Y
18.85
FCF Growth
84.57%
FCF Growth3 Y
24.89%
FCF Growth5 Y
37.24%
OCF Growth
-6.86%
OCF Growth10 Y
-5.55%
OCF Growth3 Y
11.15%
OCF Growth5 Y
27.01%
Revenue Growth
4.5x
Revenue Growth Q
8.4x
Revenue Growth3 Y
8.3x
Revenue Growth5 Y
7.32x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

22
MetricValue
Asset Turnover
EUR 0.46
Assets
EUR 2B
Cash
EUR 643.3M
Current Assets
EUR 1.1B
Current Liabilities
EUR 272.9M
Debt
EUR 12.9M
Debt EBITDA
EUR 0.1
Debt Equity
EUR 0.01
Debt FCF
EUR 0.25
Equity
EUR 1.6B
Interest Coverage
853.2
Liabilities
EUR 393M
Long Term Assets
EUR 876.5M
Long Term Liabilities
EUR 120.1M
Net Cash
EUR 630.5M
Net Cash By Market Cap
EUR 27.33
Net Cash Growth
-7.18%
Net Debt EBITDA
EUR -4.66
Net Debt Equity
EUR -0.39
Net Debt FCF
EUR -12.26
Tangible Book Value
EUR 1.6B
Tangible Book Value Per Share
EUR 22.06

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
4.08
Inventory Turnover
2.77
Net Working Capital
EUR 206.6M
Quick ratio
3.47
Working Capital
EUR 843.2M
Working Capital Turnover
EUR 0.01

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

9
MetricValue
Buyback Yield
3.1%
Dividend Growth
17.82%
Dividend Growth Years
1%
Dividend per share
EUR 0.35
Dividend Years
25
Dividend Yield
1.1%
Ex Div Date
2025-08-28
Last Dividend
EUR 0.35
Payout Ratio
39.63%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

35
MetricValue
10Y total return
-6.51%
1Y total return
20.37%
200-day SMA
27.25
3Y total return
35.62%
50-day SMA
31.64
50-day SMA vs 200-day SMA
50over200
5Y total return
-26.97%
All Time High
78.03
All Time High Change
-59.25%
All Time High Date
2018-06-20
All Time Low
6.14
All Time Low Change
417.58%
All Time Low Date
2003-08-05
ATR
0.14
Ch YTD
39.47
High
31.8
High52
35.6
High52 Date
2026-01-13
High52ch
-10.67%
Low
31.8
Low52
21.4
Low52 Date
2025-10-31
Low52ch
48.6%
Ma50ch
0.49%
Price vs 200-day SMA
16.68%
RSI
55.92
RSI Monthly
60.12
RSI Weekly
63.36
Sharpe ratio
0.63x
Sortino ratio
1.47
Total Return
4.2%
Tr YTD
39.47
Tr15y
42.1%
Tr1m
0.63%
Tr3m
-5.36%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

6
MetricValue
Operating Income
EUR 97.2M
Operating Income Growth
-5.18
Operating Income Growth Q
-6.47
Operating Income Growth3 Y
15.59
Operating Income Growth5 Y
10.92
Operating margin
10.99

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

6
MetricValue
Float
22,782,409%
Net Borrowing
-10,024,097.4
Shares Insiders
33.33%
Shares Institutions
20.3%
Shares Qo Q
0.33%
Shares Yo Y
-3.1%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

59
MetricValue
Adjusted FCF
EUR 51.4M
Average Volume
4.85x
Bv Per Share
22.48
CAPEX
EUR -43.4M
Ch10y
-21.73
Ch15y
8.87
Ch1m
0.63
Ch1y
18.66
Ch20y
30.81
Ch3m
-5.36
Ch3y
28.23
Ch5y
-34.02
Ch6m
44.55
Change
0%
Change From Open
0
Close
31.8
Days Gap
0
Depreciation Amortization
38,164,098.8
Earnings Date
2026-04-13
EBIT
EUR 97.2M
EBITDA
EUR 135.4M
EPS
EUR 1.45
F Score
4
FCF
EUR 51.4M
FCF EV Yield
3.04x
Financing CF
-109,528,523
Fiscal Year End
February
Founded
1,847
Goodwill
6,186,578.5
Graham Number
26.64575
Graham Upside
-16.21
Income Tax
EUR 22.3M
Investing CF
-91,459,950
Is Primary Listing
0
Last Earnings Date
2026-04-13
Last Report Date
2026-02-28
Lynch Fair Value
EUR 22.46
Lynch Upside
-29.38
Ma150
28.26
Ma150ch
12.54%
Ma20
31.41
Ma20ch
1.24%
Net CF
-107,635,986
Next Earnings Date
2026-07-09
Open
31.8
P FCF Ratio
44.86
P OCF Ratio
24.34
Payment Date
2025-11-06
Ppne
327,563,904.7
Price Date
2026-05-08
Price EBITDA
EUR 17.04
Ptbv Ratio
1.49
Relative Volume
20x
Revenue
884,036,929x
Tax By Revenue
2.52x
Tax Rate
17.35%
Tr20y
86.74%
Tr6m
44.55%
Z Score
4.64
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

FRA/HPX dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield
+1.1%
$0.35 annual per share
Payout ratio
+39.6%
Share of earnings returned as dividends. Below 60% is generally sustainable.
5Y dividend CAGR
-1.2%
1 consecutive years of growth
Total shareholder yield
+4.2%
Next ex-dividend date: 2025-08-28
Performance

FRA/HPX stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+20.4%
S&P 500 1Y: n/a
3Y total return
+35.6%
S&P 500 3Y: n/a
5Y total return
-27.0%
S&P 500 5Y: n/a
10Y total return
-6.5%
S&P 500 10Y: n/a
Ownership

Who owns FRA/HPX?

Insider, institutional, and short-interest positioning.

Institutional ownership
+20.3%
Share of float held by funds and institutions
Insider ownership
+33.3%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
-3.1%
Negative means the company is buying back shares.
Technical

FRA/HPX momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
55.9
Neutral momentum band
Price vs 200-day MA
+16.7%
50/200-day relationship not available
Beta (5Y)
n/a
Sensitivity to the broader market
Sharpe ratio
0.63
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About FRA/HPX

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/HPX stock rating?

fra/HPX is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/HPX analysis?

The full report lives at /stocks/fra/HPX/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/HPX?

The latest report frames fra/HPX around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/HPX page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.

fra/HPX stock profile: metrics, valuation and analysis | AI-Agent voor de Aandelenmarkt